• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用长期隧道式引流导管治疗恶性胸腔积液

Treatment of malignant pleural effusions with tunneled long-term drainage catheters.

作者信息

Pollak J S, Burdge C M, Rosenblatt M, Houston J P, Hwu W J, Murren J

机构信息

Department of Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8042, USA.

出版信息

J Vasc Interv Radiol. 2001 Feb;12(2):201-8. doi: 10.1016/s1051-0443(07)61826-0.

DOI:10.1016/s1051-0443(07)61826-0
PMID:11265884
Abstract

PURPOSE

To assess the effectiveness of tunneled pleural catheters (TPCs) in the treatment of malignant pleural effusions (MPEs).

MATERIALS AND METHODS

Twenty-eight patients with symptomatic MPEs had 31 hemithoraces treated with TPCs placed under image guidance. Chemical sclerotherapy had failed in two patients and two had symptomatic locules. Drainage was accomplished by intermittent connection to vacuum bottles. Pleurodesis was considered achieved when three consecutive outputs were scant and imaging showed no residual fluid.

RESULTS

All catheters were successfully placed. Dyspnea improved in 94% (29 of 31 hemithoraces) at 48 hours and 91% (20 of 22 patients) at 30 days. Control of the MPE was achieved in 90% of hemithoraces (28/31), although five required ancillary procedures. Pleurodesis occurred in 42% (13 of 31) of hemithoraces, including both that underwent an earlier attempt at chemical sclerotherapy and one treated locule. Continued drainage without pleurodesis controlled the effusion in 48% (15 of 31). In only 7% was hospital time necessary for care related to the TPC. Early, transient catheter-related pain was common, but only three complications (in two patients) occurred. Neither of these altered patient care.

CONCLUSIONS

Regardless of whether pleurodesis is achieved, TPCs provide effective long-term outpatient palliation of MPEs.

摘要

目的

评估隧道式胸腔导管(TPC)治疗恶性胸腔积液(MPE)的有效性。

材料与方法

28例有症状的MPE患者的31个半侧胸腔在影像引导下置入TPC进行治疗。2例患者化学硬化治疗失败,2例有症状性分隔腔。通过间歇性连接真空瓶进行引流。当连续三次引流量很少且影像学显示无残留液体时,认为胸膜固定术成功。

结果

所有导管均成功置入。48小时时94%(31个半侧胸腔中的29个)的呼吸困难得到改善,30天时91%(22例患者中的20例)得到改善。90%的半侧胸腔(28/31)实现了MPE的控制,尽管有5例需要辅助程序。42%(31个半侧胸腔中的13个)的半侧胸腔发生了胸膜固定术,包括之前尝试过化学硬化治疗的以及1个治疗过的分隔腔。持续引流但未行胸膜固定术控制了48%(31个中的15个)的胸腔积液。仅7%的患者因与TPC相关的护理需要住院治疗。早期短暂的导管相关疼痛很常见,但仅发生了3例并发症(2例患者)。这些均未改变患者的治疗。

结论

无论是否实现胸膜固定术,TPC均可为MPE提供有效的长期门诊姑息治疗。

相似文献

1
Treatment of malignant pleural effusions with tunneled long-term drainage catheters.使用长期隧道式引流导管治疗恶性胸腔积液
J Vasc Interv Radiol. 2001 Feb;12(2):201-8. doi: 10.1016/s1051-0443(07)61826-0.
2
Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.恶性胸腔积液的姑息治疗和胸膜固定术:经皮胸腔引流管的作用。
J Thorac Oncol. 2011 Apr;6(4):762-7. doi: 10.1097/JTO.0b013e31820d614f.
3
Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions.胸腔镜滑石粉与隧道式胸腔引流管治疗恶性胸腔积液的姑息疗效比较。
Ann Thorac Surg. 2012 Oct;94(4):1053-7; discussion 1057-9. doi: 10.1016/j.athoracsur.2012.01.103. Epub 2012 Apr 17.
4
The use of tunneled pleural catheters in the treatment of pleural effusions.经皮胸膜腔留置导管在胸腔积液治疗中的应用。
Curr Opin Pulm Med. 2011 Jul;17(4):237-41. doi: 10.1097/MCP.0b013e3283463dac.
5
Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.留置胸腔导管在家中治疗恶性胸腔积液:十年经验。
Eur J Surg Oncol. 2012 Dec;38(12):1161-4. doi: 10.1016/j.ejso.2012.08.021. Epub 2012 Sep 6.
6
Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.使用细孔隧道式胸腔导管对恶性胸腔积液进行门诊管理。
Respiration. 2004 Nov-Dec;71(6):559-66. doi: 10.1159/000081755.
7
Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions.超声引导下细口径胸管置入及超声监测用于复发性恶性胸腔积液的快速硬化治疗
J Ultrasound Med. 2004 Sep;23(9):1171-6. doi: 10.7863/jum.2004.23.9.1171.
8
Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients.ECOG PS 3-4 患者中使用新型小口径经皮胸腔引流导管治疗恶性胸腔积液的初步结果。
Eur J Surg Oncol. 2011 Dec;37(12):1093-8. doi: 10.1016/j.ejso.2011.09.037. Epub 2011 Oct 1.
9
Management of malignant pleural effusions.恶性胸腔积液的管理
Semin Respir Crit Care Med. 2008 Aug;29(4):405-13. doi: 10.1055/s-2008-1081283.
10
What is the best treatment for malignant pleural effusions?恶性胸腔积液的最佳治疗方法是什么?
Interact Cardiovasc Thorac Surg. 2011 May;12(5):818-23. doi: 10.1510/icvts.2010.254789. Epub 2011 Feb 16.

引用本文的文献

1
A retrospective analysis of transudative pleural effusion due to fibrosing mediastinitis.纤维化性纵隔炎所致渗出性胸腔积液的回顾性分析。
J Cardiothorac Surg. 2024 Jul 26;19(1):467. doi: 10.1186/s13019-024-02972-9.
2
Management of Malignant Pleural Effusions and Malignancy-Related Ascites.恶性胸腔积液和恶性肿瘤相关性腹水的管理
Semin Intervent Radiol. 2020 Oct;37(4):434-440. doi: 10.1055/s-0040-1715885. Epub 2020 Oct 1.
3
Amylase-Sensitive Polymeric Nanoparticles Based on Dextran Sulfate and Doxorubicin with Anticoagulant Activity.
基于硫酸葡聚糖和阿霉素的具有抗凝活性的淀粉酶敏感型聚合物纳米颗粒
Polymers (Basel). 2019 May 25;11(5):921. doi: 10.3390/polym11050921.
4
Indwelling pleural catheters: complications and management strategies.留置胸膜导管:并发症及管理策略
J Thorac Dis. 2018 Jul;10(7):4659-4666. doi: 10.21037/jtd.2018.04.160.
5
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.胸腔内基因介导细胞毒性免疫治疗恶性胸腔积液患者的 I 期研究。
Mol Ther. 2018 May 2;26(5):1198-1205. doi: 10.1016/j.ymthe.2018.02.015. Epub 2018 Feb 21.
6
Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion.使用留置胸膜导管对恶性胸腔积液进行确定性治疗。
J Bras Pneumol. 2017 Jan-Feb;43(1):14-17. doi: 10.1590/S1806-37562016000000021. Epub 2017 Jan 23.
7
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction.使用ASEPT®胸腔导管治疗恶性胸腔积液:生活质量、可行性及患者满意度
Can Respir J. 2016;2016:4273480. doi: 10.1155/2016/4273480. Epub 2016 Dec 15.
8
Complications of indwelling pleural catheter use and their management.留置胸腔导管使用的并发症及其处理。
BMJ Open Respir Res. 2016 Feb 5;3(1):e000123. doi: 10.1136/bmjresp-2015-000123. eCollection 2016.
9
Switching off malignant pleural effusion formation-fantasy or future?阻断恶性胸腔积液的形成——幻想还是未来?
J Thorac Dis. 2015 Jun;7(6):1009-20. doi: 10.3978/j.issn.2072-1439.2015.05.20.
10
Prolonged pleural catheters in the management of pleural effusions due to breast cancer.乳腺癌所致胸腔积液的胸腔内置管引流治疗。
J Thorac Dis. 2014 Feb;6(2):74-8. doi: 10.3978/j.issn.2072-1439.2013.12.38.